# FDA recall D-1410-2014

> **Bausch & Lomb, Inc.** · Class II · drug recall initiated 2014-04-10.

## Product

Muro 128 (sodium chloride) hypertonicity ophthalmic ointment, 5%, packaged in a) 1 g tube per carton, professional sample, NDC 24208-385-01, UPC 3 24208-385-01 2; b) 1/8 oz. (3.5 g) tube per carton, NDC 24208-385-55, UPC 3 24208-385-55 5; and c) 1/4 oz. (7 g) Twin Pack, Two 1/8 oz. (3.5 g) tubes per carton, NDC 24208-385-56, UPC 3 24208-385-56 3; Bausch & Lomb Incorporated, Tampa, FL  33637.

## Reason for recall

Crystallization: Crystal precipitate formation and an increase in the number of complaints associated with a gritty, sand-like feeling in the eye.

## Distribution

Nationwide, Puerto Rico, Canada, and Hong Kong.

## Key facts

- **Recall number:** D-1410-2014
- **Recalling firm:** Bausch & Lomb, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2014-04-10
- **Report date:** 2014-07-02
- **Termination date:** 2017-04-14

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Tampa, FL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1410-2014

## Citation

> AI Analytics. FDA recall D-1410-2014. Retrieved 2026-06-25 from https://api.ai-analytics.org/recall/D-1410-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*